[HTML][HTML] Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome

DGJ Cucchi, RWJ Groen, JJWM Janssen… - Drug Resistance Updates, 2020 - Elsevier
New treatment options of acute myeloid leukemia (AML) are rapidly emerging. Pre-clinical
models such as ex vivo cultures are extensively used towards the development of novel …

Single-cell sequencing: biological insight and potential clinical implications in pediatric leukemia

D Alpár, B Egyed, C Bödör, GT Kovács - Cancers, 2021 - mdpi.com
Simple Summary Leukemia is the most common type of childhood malignancy. While the
clinical management of pediatric acute leukemia, especially acute lymphoblastic leukemia …

Oncometabolic role of mitochondrial sirtuins in glioma patients

MFU Haq, MZ Hussain, I Mahjabeen, Z Akram… - PloS one, 2023 - journals.plos.org
Mitochondrial sirtuins have diverse role specifically in aging, metabolism and cancer. In
cancer, these sirtuins play dichotomous role as tumor suppressor and promoter. Previous …

Pharmacogenomic profiling of pediatric acute myeloid leukemia to identify therapeutic vulnerabilities and inform functional precision medicine

H Wang, KYY Chan, CK Cheng, MHL Ng, PY Lee… - Blood cancer …, 2022 - AACR
Despite the expanding portfolio of targeted therapies for adults with acute myeloid leukemia
(AML), direct implementation in children is challenging due to inherent differences in …

Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

ML Morales, R García-Vicente, A Rodríguez-García… - Leukemia, 2023 - nature.com
Despite the approval of several drugs for AML, cytarabine is still widely used as a
therapeutic approach. However, 85% of patients show resistance and only 10% overcome …

Integrated single-cell transcriptome analysis of CD34+ enriched leukemic stem cells revealed intra-and inter-patient transcriptional heterogeneity in pediatric acute …

D Thakral, VK Singh, R Gupta, N Jha, A Khan… - Annals of …, 2023 - Springer
To gain insights into the idiosyncrasies of CD34+ enriched leukemic stem cells, we
investigated the nature and extent of transcriptional heterogeneity by single-cell sequencing …

[HTML][HTML] Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy

Y Tian, Z Zhang, Z Zhang, X Dai - International Journal of Medical …, 2022 - ncbi.nlm.nih.gov
Cold atmospheric plasma (CAP) represents a novel onco-therapeutic approach that has
demonstrated its efficacy in many types of tumors. The efficacy of CAP is dose-dependent …

Overcoming the challenges of high quality RNA extraction from core needle biopsy

H Locy, RJM Correa, D Autaers, A Schiettecatte… - Biomolecules, 2021 - mdpi.com
The use of gene expression profiling (GEP) in cancer management is rising, as GEP can be
used for disease classification and diagnosis, tailoring treatment to underlying genetic …

Seven non-differentially expressed 'dark biomarkers' show transcriptional dysregulation in chronic lymphocytic leukemia

R Xin, X Feng, H Zhang, Y Wang, M Duan… - Personalized …, 2023 - Taylor & Francis
Aim: Transcriptional regulation is actively involved in the onset and progression of various
diseases. This study used the feature-engineering approach model-based quantitative …

[HTML][HTML] Ginsenoside Rg1 induces senescence of leukemic stem cells by upregulating p16INK4a and downregulating hTERT expression

YL Tang, XB Wang, Y Zhou… - Advances in Clinical …, 2021 - advances.umw.edu.pl
Background. Leukemic stem cells (LSCs) play an important role in the pathogenesis of
leukemia. This research attempted to clarify effects of the telomere system on ginsenoside …